Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Sign up for our Annual "Lung Cancer Highlights" Program with Dr. Natasha Leighl!
Author
Howard (Jack) West, MD

We'll kick off our monthly live webinar series, co-sponsored by GRACE along with LUNGevity Foundation, with our annual "Highlights in Lung Cancer" program. This one, featuring the leading developments from 2012, will be by Dr. Natasha Leighl, medical oncologist and lung cancer expert at Princess Margaret Hospital, as well as Assistant Professor of Medicine at the University of Toronto in Ontario, Canada. Dr. Leighl has been an internationally recognized leader in thoracic oncology and also a friend of mine for more than a decade. She's also been a friend and fan of GRACE, but we haven't reached out to her enough, so it's only fitting that we rectify that by having her provide her wonderful perspective for our Lung Cancer Highlights program.

This program will be on January 17th at 7 PM Eastern, 4 PM Pacific time, when Dr. Leighl will cover topics ranging from immunotherapy to new targets and potential targeted therapies, as well as newly identified mechanisms of acquired resistance and potential strategies for addressing this.

We'll turn her presentation into a series f free podcasts to be released on the GRACE and LUNGevity websites, but you can learn the key points first and even ask your own live questions after her live presentation. So please join us on January 17th! As always, it's free, and you can sign up through this link.

Next Previous link

Previous PostNext Post

Related Content

Image
Trial data ASCO 2024
Video
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To watch the complete playlist, click here.         
Image
Bladder Cancer Video Library 2024
Video
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.
Image
Case Based Panel
Video
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on